39 employees
Ashvattha Therapeutics is a biotechnology company that creates products that selectively target and treat human diseases.
2015
$22M
from 4 investors over 4 rounds
Ashvattha Therapeutics, Inc. raised $22M on May 31, 2020
Investors: Helios Capital, Sand Hill Angels, Plum Alley Investments and Tribe Capital